Showing results (221-230 of 227) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 227 results.
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
ESMO Open|November 28, 2024
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational studyF Schettini, F Brasó-Maristany, T Pascual, et al.
ESMO Open|June 29, 2024
Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancerF Schettini, S Nucera, F Brasó-Maristany, et al.
ESMO Open|September 25, 2025
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancerB Walbaum, O Martínez-Sáez, F Brasó-Maristany, et al.
ESMO Open|January 7, 2025
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancerL Angelats, L Paré, C Rubio-Perez, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world studyO Martínez-Sáez, M Tapia, M Marín-Aguilera, et al.
Trials|July 3, 2024
Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial)Giovanni Vento, Angela Paladini, C Aurilia, et al.
Pageof 23